Trial · NCT03537508
Adverse events186
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 186
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Somnolence | Nervous system disorders | Group 1: MenACYW Conjugate Vaccine | 975 | 1,727 | 2,319 |
| other | Somnolence | Nervous system disorders | Group 2: MENVEO | 507 | 867 | 1,273 |
| other | Teething | Gastrointestinal disorders | Group 1: MenACYW Conjugate Vaccine | 106 | 1,727 | 124 |
| other | Teething | Gastrointestinal disorders | Group 2: MENVEO | 62 | 867 | 73 |
| other | Vomiting | Gastrointestinal disorders | Group 1: MenACYW Conjugate Vaccine | 417 | 1,727 | 607 |
| other | Vomiting | Gastrointestinal disorders | Group 2: MENVEO | 196 | 867 | 276 |
| other | Decreased Appetite | Metabolism and nutrition disorders | Group 1: MenACYW Conjugate Vaccine | 704 | 1,727 | 1,246 |
| other | Decreased Appetite | Metabolism and nutrition disorders | Group 2: MENVEO | 388 | 867 | 732 |
| other | Nasopharyngitis | Infections and infestations | Group 1: MenACYW Conjugate Vaccine | 96 | 1,727 | 105 |
| other | Nasopharyngitis | Infections and infestations | Group 2: MENVEO | 50 | 867 | 62 |
| other | Otitis Media | Infections and infestations | Group 1: MenACYW Conjugate Vaccine | 79 | 1,727 | 91 |
| other | Otitis Media | Infections and infestations | Group 2: MENVEO | 48 | 867 | 64 |
| other | Upper Respiratory Tract Infection | Infections and infestations | Group 1: MenACYW Conjugate Vaccine | 214 | 1,727 | 264 |
| other | Upper Respiratory Tract Infection | Infections and infestations | Group 2: MENVEO | 130 | 867 | 162 |
| other | Crying | General disorders | Group 1: MenACYW Conjugate Vaccine | 1,023 | 1,727 | 2,366 |
| other | Crying | General disorders | Group 2: MENVEO | 541 | 867 | 1,303 |
| other | Injection Site Bruising | General disorders | Group 1: MenACYW Conjugate Vaccine | 185 | 1,727 | 380 |
| other | Injection Site Bruising | General disorders | Group 2: MENVEO | 88 | 867 | 158 |
| other | Injection Site Erythema | General disorders | Group 1: MenACYW Conjugate Vaccine | 806 | 1,727 | 3,898 |
| other | Injection Site Erythema | General disorders | Group 2: MENVEO | 409 | 867 | 2,054 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03537508/events